Drs. Rachel Meyers and David Hoff address how to use the KIDs List to help with issue of potentially inappropriate medications and excipients in pediatric patients.

Guest speakers:

David Hoff, PharmD, BCPPS, FCCP, FPPA

Moderator:

Show Notes:

[02:13-03:45] What is the KIDs List?

[03:46-05:43] Why the KIDs List is needed

[05:44-09:26] Putting the KIDs List together

[09:27-11:54] Comparing the KIDs List to Beers Criteria and STOPP/START

[11:55-13:25] Ways clinicians can use KIDs List

[13:26-16:49] Ways clinicians should not use the KIDs List

[16:50-17:39] Future plans for the KIDs list

[17:40-20:16] Unique projects of changes that have come from the KIDs List

[20:17-21:38] How frontline pharmacy staff can leverage use of the list

Links | Resources:

Journal of Pediatric Pharmacology and Therapeutics: Click here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Dr. Bryan Shaw, Senior Director of Pharmacy Analytics and Informatics. Dr. Purvi Patel, Pharmacy Informatics and Supply Chain Leadership fellow, and Dr. Brian Ortega, Pharmacy Informatics and Supply Chain Leadership PGY2 resident address training the next generation of pharmacy informatics professionals.

Guest speakers:

Purvi Patel, PharmD, PISCL

Brian Ortega, PharmD, PISCL PGY2

Moderator:

Show Notes:

[02:51-04:50] Vizient Pharmacy Informatics Training Program

[04:51-06:38] What Interested Brian and Purvi in the Program

[06:39-08:21] What sets Vizient program apart from others

[08:22-11:55] What did the program work on this year

[11:56-15:34] Advice for Pharmacy learners in informatics

Links | Resources:

PGY2 Pharmacy Informatics Residency Program (vizientinc.com)

Clinical Database | Healthcare Database Records (vizientinc.com)

Operational Data Base (vizientinc.com)

UDI fact sheet (vizientinc.com)

Vizient Analysis Shows Ending Unapproved Drugs Initiative Could Save Between $7.52 Billion and $26.59 Billion

PISCL Program application deadline is January 3rd, 2023, please apply at this link:

PISCL Application Link

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Kathryn Merkeley, program director with the Vizient PSO addresses how Patient safety organizations, or PSOs, improve patient safety and quality through the reduction of adverse events.

Guest speakers:

Moderator:

Show Notes:

[01:15-02:13] What is a PSO?

[02:14-02:59] Benefits of PSO membership to organizations

[03:00-03:41] How common is it for organizations to belong to a PSO

[03:42-04:37] ROI for health system leaders for belonging to a PSO

[04:38-05:27] How PSOs can support specifically medication safety efforts

[05:28-06:34] Standardizing approach with multiple members to your PSO

[06:35-07:16] Where are PSOs going in the future

[07:17-07:58] How frontline pharmacy staff can get involved in PSOs

Links | Resources:

Vizient Patient Safety Organization

Vizient PSO Blog: Empathetic and Effective Response to Sentinel Events and Root Cause Analysis

Vizient PSO Fact Sheet

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Drs. Meghan Swarthout and Michael Alwan share their challenges around technician recruiting and retention in the current landscape for health care organizations.

Guest speakers:

Michael Alwan, PharmD, MS

Moderator:

Show Notes:

[02:00-04:27] Setting the stage for the current pharmacy technician landscape

[04:28-06:07] How technician recruiting and retention impacts patient care and organizations

[06:08-10:25] Other strategies to address the issue

[10:26-11:38] Contrast between a career ladder and a career lattice

[11:39-15:14] Other novel approaches

[15:15-17:12] How to track success rate

[17:13-19:55] Progress seen after making changes

[19:56-21:48] How frontline staff can contribute and help improve situation

[21:49-23:03] Advice for folks struggling with the issue

Links | Resources:

Recruitment, Selection, and Retention of Pharmacy Personnel (ashp.org)

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Dr. Lorie Gull, Manager of Pharmacy Operations at UMass Memorial Medical Center and Dr. John Folstad, Pharmacy Operations Manager at Mayo Clinic Health System share their insights on the accelerating shift of eligible patient care out of an in-patient setting, pre and post COVID-19. They also discuss how treating acute care patients through hospital at home programs early adopters are demonstrating success.

Guest speakers:

John Folstad, PharmD

Moderator:

Show Notes:

[01:35 -2:47] What is a Hospital at Home program

[02:48-4:35] How patients are admitted to H@H programs

[04:36-5:46] How pharmacy services are incorporated in H@H

[05:47-07:15] How Mayo and UMass programs have developed

[07:16-07:52] Why are these relatively new programs

[07:53-09:22] Pharmacy specific challenges

[09:23-10:00] How payers are managing Hospital at Home patients

[10:01-10:51] Approaches to dispensing controlled substances

[10:52-11:13] Challenges that preclude admitting patients

[11:14-12:01] Position of regulatory agencies

[12:02-12:45] What should frontline pharmacists know about H@H

[12:46-15:10] Pearls for success

[15:11-16:09] The future of H@H programs

Links | Resources:

Hospital-level care for adult patients where they live | Hospital at Home (hahusersgroup.org)

Acute Hospital Care at Home (cms.gov)

Hospital-at-Home (ashp.org)

CMS Announces Comprehensive Strategy to Enhance Hospital Capacity Amid COVID-19 Surge | CMS

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Dr. John Schoen and Dr. Emily Diehl share the complexities and very real potential for errors of the various COVID-19 vaccines. Multiple platforms, volumes, indications, as well as the dilution and storage instructions all contribute to the risk.

Guest speakers:

Emily Diehl, PharmD, BCPPS

Moderator:

Show Notes:

[00:53-02:22] Emily and John’s backgrounds

[02:23-07:04] What’s been happening with COVID-19 Vaccines

[07:05-14:53] The concerns right now for adults and children vaccines

[14:54-21:07] What can be done to mitigate the risks

[20:08-22:34] Go to resources when you need clarity

Links | Resources:

CDC 

ISMP

Additional risk of age-related mix-ups now that our youngest patients are eligible for COVID-19 vaccines

Age-Related COVID-19 Vaccine Mix-Ups

FDA – EUA page for CV19 Click Here

ASHP – American Society of Health-System Pharmacy Click Here

AAFP – American Academy Family Physicians CV19 resources Click Here

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Carolyn Liptak, Pharmacy Executive Director at Vizient shares her expertise on Medication diversion in today’s health care environment. Diversion is a complex and pervasive issue that challenges health systems and creates significant impacts.

Guest speakers:

Moderator:

Show Notes:

[01:11-02:35] Why drug diversion is an important issue

[02:36-05:47] Drug diversion technology over the years

[05:48-08:11] How drug diversion software assists in the process

[08:12-10:30] Other gaps in detection

[10:31-12:06] What frontline staff should know about diversion

[12:07-13:21] DEA Drug Take Back Day

Links | Resources:

DEA Drug Takeback Day

HeathcareDiversion.org

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Susan Wescott, MBA, Executive Lead of Clinical Services at Alluma discusses her insights on how clinical collaboration between a health plan and ambulatory pharmacists is an effective equation for improved outcomes and savings.

Guest speaker:

Moderator:

Show Notes:

[01:45 - 05:02] Why Mayo Clinic ventured into this space

[05:03 - 08:00] What about biosimilars

[08:01 -10:18] What differentiates Alluma’s approach

[10:19 -12:35] How the pandemic impacted Alluma’s patients

[12:36 -15:30] How can Frontline Pharmacy staff utilize this in their daily work?

[15:31 -17:38] Where this is moving in the future

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Dr. Mandy Leonard, Senior Director of Drug Use Policy and Formulary Management at Cleveland Clinic and Steven Lucio, Senior Principal in Pharmacy Solutions at Vizient discuss their insights on the approval, role, and coverage of Aducanumab, the first drug in a new class approved for Alzheimer’s by the FDA’s accelerated approval process.

Guest speakers:

Steven Lucio, PharmD, BCPS

Moderator:

Show Notes:

[00:47 -3:06] Other factors driving aducanumab formulary decision making

[03:07-6:35] How CMS is managing this medication

[06:36-9:04] What should patients and families know about this medication?

[09:05-12:33] What frontline pharmacists should know about this medication

Links | Resources:

To use Aduhelm or not to use Aduhelm- that is the question…now what is the evidence? Part 1

EMERGE and ENGAGE

American Academy of Neurology statement

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed

Dr. Mandy Leonard, Senior Director of Drug Use Policy and Formulary Management at Cleveland Clinic and Steven Lucio, Senior Principal in Pharmacy Solutions at Vizient discuss their insights on the approval, role, and coverage of Aducanumab, the first drug in a new class approved for Alzheimer’s by the FDA’s accelerated approval process.

Guest speakers:

Steven Lucio, PharmD, BCPS

Moderator:

Show Notes:

[01:20 -4:16] How aducanumab fits into the treatment of Alzheimer's disease

[04:17-8:29] Accelerated Approval process and Aducanumab

[08:30-14:38] Aducanumab trials and efficacy

[14:39-17:24] Aducanumab trials and safety

Links | Resources:

EMERGE and ENGAGE

Subscribe Today!

Apple Podcasts

Amazon Podcasts

Google Podcasts

Spotify

Stitcher

Android

RSS Feed